Technology

Medtronic’s MRI leads and InterStim receive FDA approval

Medtronic has received approval from the FDA for its InterStim Micro neurostimulator and InterStim SureScan MRI leads. InterStim Micro — a small rechargeable device to deliver sacral neuromodulation (SNM) therapy — is used for treating overactive bladder (OAB), faecal incontinence (FI) and non-obstructive urinary retention. The InterStim SureScan MRI leads are used with InterStim Micro and with the recharge-free InterStim II, and allow full-body 1.5 and 3 Tesla MRI-conditional scans.  The two new products mean Medtronic offers patients and physicians a choice in SNM systems to match their preferences, lifestyle and treatment goals. Product is available for order immediately and will be delivered for patient procedures within days. Dr Steve Siegel, urologist at the Centres for Female U...

Luso announces new 750w output to Delta power supply range

Luso has announced that Delta Electronics has added a new 750W output power supply to its MEB Series of medical enclosed power supplies. The MEB-750A24 comes in a compact size at 4”x 7”x 1.6” and provides a single 24V output with 5V/2A standby output. The product can deliver full power from -20°C to 50°C without de-rating. This full feature power supply offers current sharing, conformal coating, and electric shock protection complying with 2 x MOPP suitable for type BF Medical products. Additional features include ±10% voltage trimming with options on remote on/off and power good signals. The MEB-750A24 comes with a C14 Inlet (MEB-750A24B) or alternatively a US Terminal (MEB-750A24T). It is certified to medical, ITE and home appliance safety approvals, including UL/CE/CSA/CCC and CB certif...

CE mark for COVID-19 rapid antibody test welcomed

BBI Solutions has welcomed the UK-Rapid Test Consortium’s (UK-RTC) announcement that their COVID-19 lateral flow antibody test, designed for people to use within their own homes, has received approval to go to market for professional use. The AbC-19 Rapid Test has been recognised with a CE mark for professional use, after meeting the technical performance for a rapid test as stipulated by the MHRA. This means that the test is now available for commercial distribution for use by professionals. Dr Mario Gualano, chief executive of BBI Group, said: “We are incredibly pleased that the AbC-19 Rapid test has achieved CE mark for professional use, following the high specificity and sensitivity attained in trial results. “We remain on track to deliver a test to the UK population that wil...

Developing wireless devices for medical applications

Geoff Schulteis, RF Antenna application specialist with Antenova, provides tips and advice for developing wireless devices for the medical sector, and explains how to select the most suitable antenna topology, and to achieve the best wireless performance and range from the device. Designing a wireless device for medical use brings a unique set of challenges. Medical equipment needs to perform to a high level of reliability, but when it is used close to the human body, this can introduce challenges to the operation of the antenna. This article discusses the choice of antennas available and provides some tips for integrating antennas into devices that will be used close to the body. Sometimes the very nature of the device can impact RF performance. Devices that are worn on the body can easil...

How COVID-19 will cause a long-term shift in healthcare provisions

Rupert Spiegelberg, chief executive officer at Doctorlink, outlines some of the lasting changes brought about from this pandemic.   Since the World Health Organisation (WHO) declared that the outbreak of a new Coronavirus (COVID-19) was a Public Health Emergency of International Concern in January 2020, more than three million confirmed cases have been recorded around the world. Organisations working to contain the spread of infectious diseases and supporting front line healthcare workers have become the focal point of the world’s attention, as all eyes turn on them to protect society and help us to emerge from this crisis. Without question, the pandemic has also created numerous obstacles in providing care, including concerns about viral spread within primary care, potential shortage...

Skin patch for vaccine self-administration receives Welsh government backing

Innoture, a company specialising in transdermal treatment delivery systems, has received funding from the Welsh Government to initiate proof-of-concept research into the use of its microneedle skin patch for the self-administration of COVID-19 and other vaccines. The research is being conducted at Innoture’s laboratories located in the Institute of Life Science (ILS2) at Swansea University in Wales. The patch will be tested to deliver a vaccine dose via the skin, as well as achieve a disposal process to enable at-home use. Dr Michael Graz, chief scientific officer of Innoture, said: “In the wake of the Coronavirus pandemic, vaccine developers and manufacturers face a major challenge to rapidly develop and upscale their vaccination programmes as the demand for needles, glass vials plus...

The burgeoning mental health app sector

Richard Latham, CEO and co-founder at Wellmind Health, looks at the current state, developments and trends of the mental health app sector. With over 10,000 mental health-related apps estimated to be available on the market, the industry is truly established and here to stay. As with most markets, there are differences in the levels of quality and efficacy between products, which all make bold claims about their benefits; and, as choice proliferates, individuals become more selective about what they choose to buy. This is particularly so for apps relating to something as personal and sensitive as mental health. Delivering mental health apps is a complex business, requiring app developers to master a challenging mix of psychology and technology. It’s also an exciting and rewarding sector to...

COVID-19 rapid antibody test to be rolled out in August

The COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer leading the UK-Rapid Test Consortium (UK-RTC), has received its CE mark.   This milestone means the rapid test, for detection of IgG antibodies to the SARS-CoV-2 virus (COVID-19) is now available for distribution for professional use. It will be mass produced and tests will be rolled out from the end of August. The test can be administered by healthcare professionals, such as doctors, nurses, pharmacists and healthcare workers. Following production of tens of thousands of tests across multiple production scale batches the test has been shown to be 99.40% accurate. Testing was performed at Ulster University and at the laboratories of Abingdon Health. T...

Arthritis knee brace to be available on prescription

Thuasne has announced the launch of its ActionReliever; an arthritis knee brace to be available from a GP on prescription. At a time when elective knee surgeries are being delayed, it is anticipated that the device will be highly valued by many of the five million people who suffer from knee osteoarthritis in the UK; a figure which is set to grow to 8.3 million by 2035. The Thuasne ActionReliever will act as a cost-effective solution which can bridge or delay surgery for patients with unicompartmental knee arthritis; alleviating pain while reducing the burden of cost. Research has found that patients who wear dynamic off-loading braces similar to the Thuasne ActionReliever for at least two years did not need surgery at the eight years follow up stage. Evidence shows that this device can im...

Webinar to focus on motorised implants in the human body

Motors manufacturer maxon will host a webinar focussed on motorised implants in the human body. The webinar will cover the history of implantable motors and what the future might hold. It will also offer an engineering viewpoint focussed on what’s involved in making a motor that’s going to spend its life within the body. It will be presented by maxon’s UK & Ireland medical sales engineer Matthew Dean on 25th August at 11am. Dean has been involved in selecting DC motors including surgical robots, heart pumps, and drug delivery systems among others. You can register for the webinar here. Med-Tech Innovation

Research collaboration to focus on brain oxygenation monitoring

Luciole Medical and Hôpital Fondation Adolphe de Rothschild have announced a collaboration in brain metabolism monitoring research. The two organisations are active in the area of brain hemodynamic and oxygenation monitoring. Dr. Nicolas Engrand, deputy head of intensive care at Hôpital Fondation Adolphe de Rothschild, said: “Luciole Medical’s next-generation devices address an area of immense medical need. They enable clinicians to monitor a patient’s brain function in real time and make informed, quick decisions that can be vital for their survival. I am impressed with what Luciole Medical team has achieved thus far and am looking forward to working together with Luciole’s scientists.” Luciole Medical has developed a technology platform that measures brain oxygenation parameter...

Continuity grant awarded for hypotension assistance system

Directed Systems has received a COVID-19 Continuity Grant from Innovate UK to ensure the continuity and completion of its project so its clinical decision support technology, Hypotension Decision Assist (HDA) can be brought to operating theatres in hospitals as soon as possible. HDA, is a clinical decision support Software as a Medical Device (SaMD) that is installed on a medically-rated touch-screen computer that supports anaesthetists. It provides intuitive visualisation on a single display of critical information about emerging critical cardiovascular situations to help better manage hypotension during surgery in the operating theatre.     Appropriate interventions can be used by anaesthetists to keep patients stable and avoid inter-operative hypotensi...